Recombinant multi-species STC1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STC1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. The gene contains a 5' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers. [provided by RefSeq, Jul 2008]
The Alternative Names of target: STC1,Stanniocalcin-1,STC-1,STC

Target products collectionGo to STC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T30035-Ab-1/ GM-Tg-hg-T30035-Ab-2 Human STC1 protein Human
GM-Tg-rg-T30035-Ab-1/ GM-Tg-rg-T30035-Ab-2 Rat STC1 protein Rat
GM-Tg-mg-T30035-Ab-1/ GM-Tg-mg-T30035-Ab-2 Mouse STC1 protein Mouse
GM-Tg-cynog-T30035-Ab-1/ GM-Tg-cynog-T30035-Ab-2 Cynomolgus/Rhesus macaque STC1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T30035-Ab-1/ GM-Tg-felg-T30035-Ab-2 Feline STC1 protein Feline
GM-Tg-cang-T30035-Ab-1/ GM-Tg-cang-T30035-Ab-2 Canine STC1 protein Canine
GM-Tg-bovg-T30035-Ab-1/ GM-Tg-bovg-T30035-Ab-2 Bovine STC1 protein Bovine
GM-Tg-equg-T30035-Ab-1/ GM-Tg-equg-T30035-Ab-2 Equine STC1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T30035-Ab-1/ GM-Tg-hg-T30035-Ab-2; GM-Tg-rg-T30035-Ab-1/ GM-Tg-rg-T30035-Ab-2;
GM-Tg-mg-T30035-Ab-1/ GM-Tg-mg-T30035-Ab-2; GM-Tg-cynog-T30035-Ab-1/ GM-Tg-cynog-T30035-Ab-2;
GM-Tg-felg-T30035-Ab-1/ GM-Tg-felg-T30035-Ab-2; GM-Tg-cang-T30035-Ab-1/ GM-Tg-cang-T30035-Ab-2;
GM-Tg-bovg-T30035-Ab-1/ GM-Tg-bovg-T30035-Ab-2; GM-Tg-equg-T30035-Ab-1/ GM-Tg-equg-T30035-Ab-2
Products Name STC1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name STC1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STC1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.